- Home
- SATX vs THRD Comparison
SATX vs THRD Comparison
Compare SATX & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATX
- THRD
- Stock Information
- Founded
- SATX 2012
- THRD 2019
- Country
- SATX Israel
- THRD United States
- Employees
- SATX N/A
- THRD N/A
- Industry
- SATX Radio And Television Broadcasting And Communications Equipment
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- SATX Technology
- THRD Health Care
- Exchange
- SATX Nasdaq
- THRD Nasdaq
- Market Cap
- SATX 251.3M
- THRD 238.7M
- IPO Year
- SATX N/A
- THRD 2022
- Fundamental
- Price
- SATX $2.90
- THRD $5.46
- Analyst Decision
- SATX Strong Buy
- THRD Hold
- Analyst Count
- SATX 2
- THRD 3
- Target Price
- SATX $2.25
- THRD $5.00
- AVG Volume (30 Days)
- SATX 298.8K
- THRD 273.8K
- Earning Date
- SATX 05-22-2025
- THRD 08-07-2025
- Dividend Yield
- SATX N/A
- THRD N/A
- EPS Growth
- SATX N/A
- THRD N/A
- EPS
- SATX N/A
- THRD N/A
- Revenue
- SATX $23,654,000.00
- THRD N/A
- Revenue This Year
- SATX $50.67
- THRD N/A
- Revenue Next Year
- SATX $1.64
- THRD N/A
- P/E Ratio
- SATX N/A
- THRD N/A
- Revenue Growth
- SATX 130.79
- THRD N/A
- 52 Week Low
- SATX $0.58
- THRD $3.18
- 52 Week High
- SATX $2.97
- THRD $16.02
- Technical
- Relative Strength Index (RSI)
- SATX 79.84
- THRD 80.73
- Support Level
- SATX $2.88
- THRD $5.37
- Resistance Level
- SATX $2.90
- THRD $5.32
- Average True Range (ATR)
- SATX 0.02
- THRD 0.05
- MACD
- SATX -0.03
- THRD 0.00
- Stochastic Oscillator
- SATX 91.67
- THRD 90.32
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd is engaged in developing end-to-end next-generation satellite communication systems. This includes satellite payloads, user terminals, and modems, which are built on powerful in-house designed chipsets. Their products feature modems equipped with Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the entire DVB-RCS2 / DVB-S2X industry standards as well as a complete SDR for any other waveform. The company has a geographical presence in the U.S. & Canada, the UK, and Other countries, with the majority of its revenue generated from the U.S. and Canada.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.